| Trial ID: | L2191 |
| Source ID: | NCT03410173
|
| Associated Drug: |
Taurine
|
| Title: |
Taurine Supplementation on Cognitive Function in Patients With Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Taurine|Cognitive Decline|Diabetes Mellitus
|
| Interventions: |
DRUG: Taurine|DRUG: Placebo
|
| Outcome Measures: |
Primary: Changes of cognitive function assessed by cognitive function scale after 12 weeks., Baseline, 12weeks(End of Trial) | Secondary: 24-hours mean blood pressure., Baseline, 12weeks(End of Trial)|Fasting plasma glucose, Baseline, 12weeks(End of Trial)|HbA1c, Baseline, 12weeks(End of Trial)|Lipid profile (triglyceride, total cholesterol, LDL-c; HDL-c; mmol/L), Baseline, 12weeks(End of Trial)|Carotid intima-media thickness(IMT), Baseline, 12weeks(End of Trial)|Body mass index(BMI), Baseline, 12weeks(End of Trial)|Fasting serum insulin., Baseline, 12weeks(End of Trial)
|
| Sponsor/Collaborators: |
Sponsor: Third Military Medical University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
200
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2017-01
|
| Completion Date: |
2018-06
|
| Results First Posted: |
|
| Last Update Posted: |
2018-01-25
|
| Locations: |
The third hospital affiliated to the Third Military Medical University, Chongqing, Chongqing, 400042, China
|
| URL: |
https://clinicaltrials.gov/show/NCT03410173
|
